BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced meeting the primary endpoint on an interim analysis of a ...
More than 7 million Americans struggle with essential tremor (ET), but only one in 10 ET patients is satisfied with their current treatment. Cala Health — a San Mateo, California-based bioelectronic ...
388813 01: A photo illustration depicts a person typing May 4, 2001 in Denver, CO. National Academy of Sciences estimates that musculoskeletal disorders such as carpal-tunnel syndrome, tendinitis, and ...
Cala announced the appointment of Deanna Harshbarger as Chief Executive Officer (CEO) and as a member of the Company's Board of Directors, effective immediately. Concurrently, Cala has appointed ...
Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...
The MarketWatch News Department was not involved in the creation of this content. Seasoned finance leader, Kevin Strange, joins Cala as CFO VPs of Sales, Marketing and Research collectively bring ...
SAN MATEO, Calif. and HONOLULU, Oct. 6, 2025 /PRNewswire/ -- Cala ®, the bioelectronic medicine leader, announced today the publication of a groundbreaking study in the journal Brain Stimulation ...
After securing Medicare coverage for its wearable neurostimulator to help people control their hand tremors, Cala Health has raised $50 million to boost its commercial trajectory. The Silicon ...
SAN MATEO, Calif., Oct. 25, 2023 /PRNewswire/ -- Cala, the bioelectronic medicine leader setting a new standard of care for chronic disease, was named in TIME's Best Inventions of 2023 for the Cala ...
A wearable, artificial intelligence (AI)-driven, continuous-use transcutaneous peripheral nerve stimulation (TPNS) device was linked to significant improvement in upper limb tremor in adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback